142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

309729
Congenital Cytomegalovirus: The Utah Policy and Public Health Experience

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 9:30 AM - 9:50 AM

Alyson Ward, MS, CHES , National Center for Hearing Assessment and Management, Utah State University, Logan, UT
Stephanie McVicar, Au.D., CCC-A , Maternal and Child Health Program, Children with Special Healthcare Needs, Utah Department of Health, Salt Lake City, UT
Sara Doutre, M.A. Education and Policy Studies , Parent, Logan, UT
Ronda Menlove, Ph.D. , Utah State University, Logan, UT
Congenital cytomegalovirus (CMV) is the most common congenital infection found in developed countries and can pass trans-placentally to the fetus resulting in multiple disabilities including hearing loss. In fact, CMV accounts for approximately 20% of pediatric hearing loss. Despite CMV causing more long-term problems and childhood deaths than Fetal Alcohol Syndrome, neural tube defects, and Down Syndrome, there is limited public awareness that the virus can be prevented by good hygiene practices.  Spurred by grassroots advocacy by parents with children affected by CMV sequelae, Utah lawmakers led the nation by passing HB 81in July 2013. This law mandates that the Utah Department of Health (UDOH), specifically the Early Hearing Detection and Intervention program, implement an education campaign that 1) targets pregnant women (or women who may become pregnant) and childcare providers about the prevention, transmission, occurrence, sequelae, diagnosis, and treatment of CMV and 2) notifies medical practitioners of the mandate to test all babies who fail two newborn hearing screenings for congenital cytomegalovirus prior to 21 days of age. To meet the 21-day window, Utah Newborn Hearing Screening protocols were revised so that all infants are screened and then re-screened (for those who fail the first screening) by 14 days, compared to the previous 30-day protocol. The CMV education efforts undertaken by UDOH were devised and implemented within a short timeframe, making stakeholder engagement imperative. This presentation will share Utah’s experience of taking a grassroots effort full circle, from parent advocacy, to legislation, to public health.

Learning Areas:

Implementation of health education strategies, interventions and programs
Protection of the public in relation to communicable diseases including prevention or control
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
Discuss the important linkages between public health and policy in regards to implementing a comprehensive CMV initiative. Describe the necessary steps they need to take to replicate the Utah CMV bill in their own state. Identify the importance of stakeholder collaboration in implementing CMV education and testing in their state.

Keyword(s): Public Health Policy, Health Promotion and Education

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have a M.S. in Health Education and a CHES certification and have worked in public health for over ten years. I have been involved in health promotion, education, research, policy, evaluation, grant development, and grant review from the community to national levels. Currently, I’m involved in the planning and implementation of Utah’s HB 81, which mandates the Utah Department of Health to conduct a public-centered and physician-centered education campaigns about Cytomegalovirus.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.